Emily Papineau, PharmD
Disclosures: Nothing to disclose - 06/29/2022

Dr. Emily Papineau serves as the Executive Director of Ambulatory Pharmacy Services for Community Health Network, Indianapolis, IN. Dr. Papineau graduated with her Doctor of Pharmacy from Butler University College of Pharmacy and Health Sciences and then completed both a Pharmacy Practice residency and specialty residency in Primary Care. She began her career as a board certified pharmacotherapy specialist, holding a joint faculty appointment with Butler University while practicing at Community Group Family Medicine for twelve years, where she established collaborative drug therapy management (CDTM) agreements within Community Health Network. In her leadership roles, she has facilitated establishment and expansion of CDTM agreements with over 350 providers within the organization. Growing pharmacy services from a team of one to approximately 50 ambulatory care pharmacists, these pharmacists utilize CDTM agreements to optimize medication regimens and provide extensive medication/disease state education to patients in primary and specialty care areas.

Dr. Papineau’s additional responsibilities include oversight of the Medication Assistance Program, which she established to help patients obtain medications for less cost. This program is comprised of a team of pharmacy technicians and medical assistants that provided over $45 million in medication savings to patients in 2021 alone. She also oversees the Ambulatory Medication Procurement department that manages the formulary selection for clinic-administered drugs, as well as centralizes the purchasing and distribution of >$36 million of medications annually to over 300 ambulatory locations. She works collaboratively with others in ambulatory policy and protocol development, as well as, numerous medication safety initiatives such as introducing barcode scanning of medications in the ambulatory sites of care, criteria for safe medication refill practices, management of sample medications, drug diversion prevention, and transitioning from paper to electronic infusion therapy orders